Skip to content

Scilex Holding Company SCLX Deferred Transaction Costs Related To Semnur Merger Included In Accrued Expenses And Account Payable

Deferred Transaction Costs Related To Semnur Merger Included In Accrued Expenses And Account Payable at other companies

PVL
Palvella TherapeuticsPVLA
$0-100%
AMC Entertainment Holdings logo
AMC Entertainment HoldingsAMC
$1.1M-63.3%
KLR
Kalaris Therapeutics, Inc. Common StockKLRS
$337K-46.4%
Installed Building Products logo
Installed Building ProductsIBP
$700K+75.0%
TuHURA Biosciences, Inc. logo
TuHURA Biosciences, Inc.HURA
$125K
CTO
Citius Oncology, Inc.CTOR
$688.57K

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Gross profit$4.2M+15.1%
Operating income-$32.2M-15.3%
Net income-$45.7M-75.0%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total debt$95.4M+130%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$54.86M+88.7%
Enterprise value$146.86M+120%
P/S1.6×+1.0×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%

Returns & leverage

See full
Return on equity170.9%
Debt / equity0.3×
Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept sclx:DeferredTransactionCostsRelatedToSemnurMergerIncludedInAccruedExpensesAndAccountPayable.

The official record: Scilex Holding Company’s 10-K, filed April 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's deferred transaction costs related to semnur merger included in accrued expenses and account payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scilex Holding Company's deferred transaction costs related to semnur merger included in accrued expenses and account payable?
Scilex Holding Company (SCLX) reported deferred transaction costs related to semnur merger included in accrued expenses and account payable of $0 in Q4 2025.
How has Scilex Holding Company's deferred transaction costs related to semnur merger included in accrued expenses and account payable changed year-over-year?
Scilex Holding Company's deferred transaction costs related to semnur merger included in accrued expenses and account payable decreased by 100.0% year-over-year, from $1.15M to $0.
What does deferred transaction costs related to semnur merger included in accrued expenses and account payable mean?
This captures the costs associated with a specific merger or acquisition that have been accrued but not yet paid in cash. It represents the short-term liability burden incurred to execute strategic growth initiatives. Monitoring these costs is essential for evaluating the total expense of M&A activity and its impact on working capital.